{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:08:40Z","timestamp":1774282120459,"version":"3.50.1"},"reference-count":23,"publisher":"Akademiai Kiado Zrt.","issue":"12","license":[{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2026,3,22]]},"abstract":"\n A Magyar Arc-, \u00c1llcsont- \u00e9s Sz\u00e1jseb\u00e9szeti T\u00e1rsas\u00e1g kezdem\u00e9nyez\u00e9s\u00e9re a Magyar\n Orvost\u00e1rsas\u00e1gok \u00e9s Egyes\u00fcletek Sz\u00f6vets\u00e9ge \u201eInterdiszciplin\u00e1ris konszenzus az\n antireszorpt\u00edv szerek okozta \u00e1llcsontnekr\u00f3zis elker\u00fcl\u00e9s\u00e9re\u201d c\u00edmmel a\n Magyar Osteol\u00f3giai \u00e9s Osteoarthrol\u00f3giai T\u00e1rsas\u00e1g (MOOT), a Magyar\n Onkol\u00f3gusok T\u00e1rsas\u00e1ga (MOT), a Magyar Klinikai Onkol\u00f3giai T\u00e1rsas\u00e1g (MKOT), a\n Magyar Fogorvosok Egyes\u00fclete (MFE), a Magyar Fogorvosok Implantol\u00f3giai\n T\u00e1rsas\u00e1ga (MAFIT) \u00e9s a H\u00e1ziorvosok Online Szervezete (HAOSZ)<\/jats:italic>\n r\u00e9szv\u00e9tel\u00e9vel interdiszciplin\u00e1ris f\u00f3rumot szervezett. A f\u00f3rumon \u00e9s az azt k\u00f6vet\u0151\n egyeztet\u00e9seken alakult ki a mell\u00e9kelt dokumentum, amely minden r\u00e9sztvev\u0151\n \u00e1ll\u00e1spontj\u00e1t t\u00fckr\u00f6zi. Tekintettel arra, hogy a k\u00f3rk\u00e9p etiopatogenezise nem\n teljesen tiszt\u00e1zott, valamint arra, hogy hat\u00e9kony ter\u00e1pi\u00e1s opci\u00f3 nem \u00e1ll\n rendelkez\u00e9sre, a megel\u0151z\u00e9snek kiemelt jelent\u0151s\u00e9ge van. A fenti t\u00e1rsas\u00e1gok \u00e9s az\n \u00e1ltaluk ell\u00e1tott p\u00e1ciensek egyar\u00e1nt abban \u00e9rdekeltek, hogy minimaliz\u00e1lj\u00e1k (az\n egyes, helyes indik\u00e1ci\u00f3kban, vitathatatlanul indokoltan adott, igen hat\u00e9kony)\n atireszorpt\u00edv szerek mell\u00e9khat\u00e1sait. Emellett c\u00e9lunk, hogy eloszlassuk a\n (betegek \u00e9s orvosok eset\u00e9n is olykor megfigyelhet\u0151) t\u00e1j\u00e9kozatlans\u00e1gb\u00f3l ered\u0151\n f\u00e9lelmet, defenz\u00edv hozz\u00e1\u00e1ll\u00e1st, amely miatt az antireszorpt\u00edv kezel\u00e9s alatt \u00e1ll\u00f3\n betegekn\u00e9l sz\u00fcks\u00e9ges kezel\u00e9sek maradhatnak el, tol\u00f3dhatnak ki id\u0151ben. A fenti\n szakter\u00fcletek egy r\u00e9sz\u00e9t azok a szakm\u00e1k alkotj\u00e1k, amelyek gy\u00f3gy\u00edt\u00f3 tev\u00e9kenys\u00e9ge\n sor\u00e1n ezek a mell\u00e9khat\u00e1sok el\u0151fordulhatnak, m\u00edg m\u00e1s szakm\u00e1k a m\u00e1r kialakult\n osteonecrosis kezel\u00e9s\u00e9vel foglalkoznak. A konszenzusdokumentum \u2013 prevent\u00edv\n szeml\u00e9let\u0171, szakmai tartalm\u00e1n\u00e1l fogva \u2013 felt\u00e9tlen\u00fcl alkalmas arra, hogy\n \u00fatmutat\u00e1st adjon az antireszorpt\u00edv kezel\u00e9st elrendel\u0151 orvosok \u00e9s a fogorvosok\n sz\u00e1m\u00e1ra, az ilyen betegek megfelel\u0151 ir\u00e1ny\u00edt\u00e1s\u00e1ra, a kezel\u00e9sek id\u0151z\u00edt\u00e9s\u00e9re, az\n interdiszciplin\u00e1ris egy\u00fcttm\u0171k\u00f6d\u00e9sre. Orv Hetil. 2026; 167(12): 450\u2013455.\n <\/jats:p>","DOI":"10.1556\/650.2026.33509","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:39:59Z","timestamp":1774280399000},"page":"450-455","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":0,"title":["Interdiszciplin\u00e1ris konszenzus az antireszorpt\u00edv szerek okozta \u00e1llcsontnekr\u00f3zis elker\u00fcl\u00e9s\u00e9re"],"prefix":"10.1556","volume":"167","author":[{"given":"Zsolt","family":"N\u00e9meth","sequence":"first","affiliation":[{"name":"Semmelweis Egyetem, Fogorvostudom\u00e1nyi Kar, Arc-\u00c1llcsont-Sz\u00e1jseb\u00e9szeti \u00e9s Fog\u00e1szati Klinika Budapest, M\u00e1ria u. 52., 1085 Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3zsef","family":"Szalma","sequence":"additional","affiliation":[{"name":"P\u00e9csi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Arc-, \u00c1llcsont- \u00e9s Sz\u00e1jseb\u00e9szeti Tansz\u00e9k P\u00e9cs Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szilvia","family":"M\u00e9sz\u00e1ros","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Belgy\u00f3gy\u00e1szati \u00e9s Onkol\u00f3giai Klinika Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"Hidegh\u00e9ty","sequence":"additional","affiliation":[{"name":"Szegedi Tudom\u00e1nyegyetem, Szent-Gy\u00f6rgyi Albert Klinikai K\u00f6zpont, Onkoter\u00e1pi\u00e1s Klinika Szeged Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3zsef","family":"L\u00f6vey","sequence":"additional","affiliation":[{"name":"University Hospital, Department of Oncology Oslo Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"Nagy","sequence":"additional","affiliation":[{"name":"Szegedi Tudom\u00e1nyegyetem, Fogorvostudom\u00e1nyi Kar, Sz\u00e1jseb\u00e9szeti Tansz\u00e9k Szeged Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1rp\u00e1d","family":"Jo\u00f3b-Fancsaly","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, Fogorvostudom\u00e1nyi Kar, Arc-\u00c1llcsont-Sz\u00e1jseb\u00e9szeti \u00e9s Fog\u00e1szati Klinika Budapest, M\u00e1ria u. 52., 1085 Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anik\u00f3","family":"Mar\u00e1z","sequence":"additional","affiliation":[{"name":"Szegedi Tudom\u00e1nyegyetem, Szent-Gy\u00f6rgyi Albert Klinikai K\u00f6zpont, Onkoter\u00e1pi\u00e1s Klinika Szeged Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Tak\u00e1csi-Nagy","sequence":"additional","affiliation":[{"name":"Orsz\u00e1gos Onkol\u00f3giai Int\u00e9zet, Sug\u00e1rter\u00e1pi\u00e1s K\u00f6zpont Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szabolcs","family":"B\u00e9k\u00e1ssy","sequence":"additional","affiliation":[{"name":"A H\u00e1ziorvosok Online Szervezet\u00e9nek eln\u00f6ke Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sz\u00f3fia","family":"Szentp\u00e9teri","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, Fogorvostudom\u00e1nyi Kar, Arc-\u00c1llcsont-Sz\u00e1jseb\u00e9szeti \u00e9s Fog\u00e1szati Klinika Budapest, M\u00e1ria u. 52., 1085 Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Vereb","sequence":"additional","affiliation":[{"name":"Szegedi Tudom\u00e1nyegyetem, Szent-Gy\u00f6rgyi Albert Klinikai K\u00f6zpont, Arc-, \u00c1llcsont- \u00e9s Sz\u00e1jseb\u00e9szeti Klinika Szeged Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2570-0009","authenticated-orcid":true,"given":"Mih\u00e1ly","family":"Vaszilk\u00f3","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, Fogorvostudom\u00e1nyi Kar, Arc-\u00c1llcsont-Sz\u00e1jseb\u00e9szeti \u00e9s Fog\u00e1szati Klinika Budapest, M\u00e1ria u. 52., 1085 Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, et al. American Association of\n Oral and Maxillofacial Surgeons position paper on medication-related\n osteonecrosis of the jaw - 2014 update. J Oral Maxillofac Surg. 2014; 72:\n 1938-1956. Erratum: J Oral Maxillofac Surg. 2015; 7:1440. Erratum: J Oral\n Maxillofac Surg. 2015; 73: 1879.\n https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","DOI":"10.1016\/j.joms.2014.04.031"},{"key":"R2","unstructured":"N\u00e9meth Z, Bogd\u00e1n S, Jo\u00f3b-Fancsaly \u00c1, et al. Medication-related\n osteonecrosis of the jaw (MRONJ) during the treatment of cancer patients.\n [Gy\u00f3gyszer okozta \u00e1llcsontnekr\u00f3zis (MRONJ) a daganatos betegek kezel\u00e9sekor.]\n Magy Onkol. 2025; 69: 118-127. [Hungarian]"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, et al. American association of\n oral and maxillofacial surgeons position paper on medication-related\n osteonecrosis of the jaws - 2022 update. J Oral Maxillofac Surg. 2022; 80:\n 920-943. https:\/\/doi.org\/10.1016\/j.joms.2022.02.008","DOI":"10.1016\/j.joms.2022.02.008"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Veszelyn\u00e9 Kot\u00e1n E, Bartha-Lieb T, Parisek Z, et al. Database\n analysis of the risk factors of bisphosphonate-related osteonecrosis of the jaw\n in Hungarian patients. BMJ Open 2019; 9: e025600.\n https:\/\/doi.org\/10.1136\/bmjopen-2018-025600","DOI":"10.1136\/bmjopen-2018-025600"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Yarom N, Shapiro CL, Peterson DE, et al. Medication-related\n osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline. J Clin\n Oncol. 2019; 37: 2270-2290.\n https:\/\/doi.org\/10.1200\/JCO.19.01186","DOI":"10.1200\/JCO.19.01186"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Szentp\u00e9teri Sz, Rest\u00e1r L, N\u00e9meth Zs, et al. Prognostic factors of\n the medication-related osteonecrosis of the jaw. [A gy\u00f3gyszer okozta\n \u00e1llcsontnekr\u00f3zis progn\u00f3zis\u00e1t befoly\u00e1sol\u00f3 faktorok.] Orv Hetil. 2020; 161:\n 283-289. [Hungarian]\n https:\/\/doi.org\/10.1556\/650.2019.31621","DOI":"10.1556\/650.2019.31621"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Bojtor B, Balla B, Vaszilk\u00f3 M, et al. Genetic background of\n medication-related osteonecrosis of the jaw: current evidence and future\n perspectives. Int J Mol Sci. 2024; 25: 10488.\n https:\/\/doi.org\/10.3390\/ijms251910488","DOI":"10.3390\/ijms251910488"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Coleman R, Hadji P, Body JJ, et al. Bone health in cancer: ESMO\n clinical practice guidelines. Ann Oncol. 2020; 31: 1650-1663.\n https:\/\/doi.org\/10.1016\/j.annonc.2020.07.019","DOI":"10.1016\/j.annonc.2020.07.019"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Kammerhofer G, Vegh D, B\u00e1nyai D, et al. Association between\n hyperglycemia and medication-related osteonecrosis of the jaw (MRONJ). J Clin\n Med. 2023; 12: 2976.\n https:\/\/doi.org\/10.3390\/jcm12082976","DOI":"10.3390\/jcm12082976"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Szentp\u00e9teri S, K\u00f3sa J, Juh\u00e1sz HD, et al. Examination of certain\n single-nucleotide polymorphisms of interleukins 1A and 1B in medication-related\n osteonecrosis of the jaw - an ambirectional cohort study. J Craniomaxillofac\n Surg. 2024; 52: 1133-1139.\n https:\/\/doi.org\/10.1016\/j.jcms.2024.06.007","DOI":"10.1016\/j.jcms.2024.06.007"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Vaszilk\u00f3 M, Kov\u00e1cs E, Rest\u00e1r L, et al. Potential significance of\n antiestrogen therapy in the development of bisphosphonate related osteonecrosis\n of the jaw. Craniomaxillofac Surg. 2014; 42: 1932-1936.\n https:\/\/doi.org\/10.1016\/j.jcms.2014.08.002","DOI":"10.1016\/j.jcms.2014.08.002"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Vereb T, Boda K, Czak\u00f3 L, et al. Cloud-based multicenter data\n collection and epidemiologic analysis of bisphosphonate-related osteonecrosis of\n the jaws in a central European population. J Clin Med. 2020; 9: 426.\n https:\/\/doi.org\/10.3390\/jcm9020426","DOI":"10.3390\/jcm9020426"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Brunner C, Arvandi M, Marth C, et al. Incidence of\n medication-related osteonecrosis of the jaw in patients with breast cancer\n during a 20-year follow-up: a population-based multicenter retrospective study.\n J Clin Oncol. 2025; 43: 180-188.\n https:\/\/doi.org\/10.1200\/JCO.24.00171","DOI":"10.1200\/JCO.24.00171"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Bojtor B, Vaszilk\u00f3 M, Armos R, et al. Analysis of SIRT1 gene SNPs\n and clinical characteristics in medication-related osteonecrosis of the jaw. Int\n J Mol Sci. 2024; 25: 3646.\n https:\/\/doi.org\/10.3390\/ijms25073646","DOI":"10.3390\/ijms25073646"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Black DM, Reid IR, Cauley JA, et al. The effect of 6 versus 9 years\n of zoledronic acid treatment in osteoporosis: a randomized second extension to\n the HORIZON-Pivotal fracture trial (PFT). J Bone Miner Res. 2015; 30: 934-944.\n https:\/\/doi.org\/10.1002\/jbmr.2442","DOI":"10.1002\/jbmr.2442"},{"key":"R16","unstructured":"Baghalipour N, Moztarzadeh O, Samar W, et al. Comprehensive review\n of prevention and management strategies for medication-related osteonecrosis of\n the jaw (MRONJ). Oral Health Prev Dent. 2025; 23: 403-417."},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Bedogni A, Mauceri R, Fusco V, et al. Italian position paper\n (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ). Oral Dis.\n 2024; 30: 3679-3709.\n https:\/\/doi.org\/10.1111\/odi.14887","DOI":"10.1111\/odi.14887"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Hasegawa T, Ueda N, Yamada SI, et al. Denosumab-related\n osteonecrosis of the jaw after tooth extraction and the effects of a short drug\n holiday in cancer patients: a multicenter retrospective study. Osteoporos Int.\n 2021; 32: 2323-2333. Erratum: Osteoporos Int. 2023; 34: 1823-1825.\n https:\/\/doi.org\/10.1007\/s00198-023-06833-4","DOI":"10.1007\/s00198-023-06833-4"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Cabras M, Gambino A, Broccoletti R, et al. Lack of evidence in\n reducing risk of MRONJ after teeth extractions with systemic antibiotics. J Oral\n Sci. 2021; 63: 217-226.\n https:\/\/doi.org\/10.2334\/josnusd.21-0016","DOI":"10.2334\/josnusd.21-0016"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Ristow O, R\u00fcckschlo\u00df T, Moratin J, et al. Wound closure and\n alveoplasty after preventive tooth extractions in patients with antiresorptive\n intake. A randomized pilot trial. Oral Dis. 2021; 27: 532-546.\n https:\/\/doi.org\/10.1111\/odi.13556","DOI":"10.1111\/odi.13556"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Szentp\u00e9teri S, Schmidt L, Rest\u00e1r L, et al. The effect of\n platelet-rich fibrin membrane in surgical therapy of medication-related\n osteonecrosis of the jaw. J Oral Maxillofac Surg. 2020; 78: 738-748.\n https:\/\/doi.org\/10.1016\/j.joms.2019.12.008","DOI":"10.1016\/j.joms.2019.12.008"},{"key":"R22","unstructured":"Lorenzo-Pouso AI, P\u00e9rez-Say\u00e1ns M, Gonz\u00e1lez-Palanca S, et al.\n Biomarkers to predict the onset of bisphosphonate-related osteonecrosis of the\n jaw: a systematic review. Med Oral Patol Oral Cir Bucal. 2019; 24:\n e26-e36."},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Wei LY, Chiu CM, Kok SH, et al. Prognostic indicators in\n medication-related osteonecrosis of the jaw: a systematic review and\n meta-analysis. Osteoporos Int. 2025; 36: 969-979.\n https:\/\/doi.org\/10.1007\/s00198-025-07464-7","DOI":"10.1007\/s00198-025-07464-7"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/167\/12\/article-p450.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/167\/12\/article-p450.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/167\/12\/article-p450.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:40:07Z","timestamp":1774280407000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/167\/12\/article-p450.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,22]]},"references-count":23,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.1556\/650.2026.33509","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,22]]}}}